Navigation Links
Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
Date:1/8/2008

partner product candidates may not issue, patents that have issued may not be enforceable or sufficient to protect against competitive products, or intellectual property licenses from third parties may be required in the future, (vi) the outcome of any existing or future intellectual property or other litigation related to the company's proprietary product candidates, and (vii) potential competition from existing approved products (branded or generic) or product candidates under development by other companies could negatively impact the commercial potential of the company's product candidates due to such competitive factors as efficacy and safety profiles, pricing, and reimbursement by third party payers. Other important risks and uncertainties are detailed in the company's reports and other filings with the Securities and Exchange Commission (SEC), including its most recent Quarterly Report on Form 10-Q filed with the SEC on November 9, 2007. Actual results could differ materially from the forward-looking statements contained in this press release. The company undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise. No information regarding or presented at the company's R&D day either posted on the company's website or presented orally or visually through the Webcast is intended to be incorporated by reference in this press release.

Contacts:

Tim Warner (650) 283-4915 or twarner@nektar.com

Stephan Herrera (415) 488-7699 or sherrera@nektar.com

Jennifer Ruddock (650) 631-4954 or jruddock@nektar.com


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
2. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
3. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
4. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
5. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
6. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
7. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation ... to support older adults suffering from the severe ... AARP and its members are committed to helping those ... AARP and AARP Foundation will match dollar-for-dollar contributions up ... aid. The matching program will be administered through AARP ...
(Date:1/15/2014)... -- Celsion Corporation (the "Company") (NASDAQ: CLSN ... from institutional investors to purchase an aggregate of ... in an at-the-market registered direct offering, led by ... Company entered into definitive purchase agreements with these ... sell an aggregate of 3,603,603 shares of its ...
(Date:1/15/2014)... , January 15, 2014 Shire ... it has waived the Office of Fair Trading (OFT) approval ... outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... longer conditional on OFT approval, and Shire expects to complete ... scheduled expiration time, subject to the satisfaction of all of ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... For the second consecutive year, the Exergen temporal ... which stock the product, according to Nielsen and Information ... thermometers, including national brands and private label products, were ... market share has risen to 20 percent of all ...
... LLC announced today that Dr. David Hangauer, who served as ... as Chief Scientific Officer of the Company.   ... discovered and designed both of our lead compounds, KX01 and ... I have worked together with him for the last 7 ...
Cached Medicine Technology:The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer 2The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer 3
(Date:4/14/2014)... Porter Graham Child Development Institute have released their ... to prepare four-year-olds for success in kindergarten. According ... show significant gains across all areas of learning. ... greater rate during their participation in NC Pre-K ... scientist Ellen Peisner-Feinberg, who leads the FPG team ...
(Date:4/14/2014)... children with uncomplicated acute appendicitis is a reasonable alternative ... missed school days, according to a pilot study. The ... and published online April 12 in the Journal ... first prospective study on nonoperative management of acute appendicitis ... Researchers enrolled 77 patients age 7 to 17 who ...
(Date:4/14/2014)... shows that domestic abuse is closely linked to ... stress disorder (PTSD), in mothers. The research also ... with specific mental health problems. The work was ... Simon Fraser University and the University of British ... how intimate partner abuse physical, psychological and ...
(Date:4/13/2014)... program for adolescent girls in Kenyan slums sharply ... who live in an environment where women have ... new study shows. , The findings, by researchers ... Packard Children,s Hospital Stanford and the nongovernmental organization ... in combating an appallingly common hazard among girls ...
(Date:4/11/2014)... a severe disease for which there is still no ... what happens in the brain of a schizophrenic person, ... proteins in the brains of rats that have been ... new and better medicines. , Seven per cent of ... have tried for centuries to understand the disease, they ...
Breaking Medicine News(10 mins):Health News:Study gives high marks to NC Pre-K program 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Study links domestic abuse to mental health problems in new mothers 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4Health News:Protein researches closing in on the mystery of schizophrenia 2Health News:Protein researches closing in on the mystery of schizophrenia 3
... that one in three early-stage breast cancer patients who ... they did not fully understand their discussions with physicians ... About one in four experienced distress when receiving their ... a peer-reviewed journal of the American Cancer Society, the ...
... Scientists at the Stanford University School of Medicine have ... device to virtually separate a whole-blood sample into its different ... any one of those cell types. In a study ... , the scientists reported that they had successfully used the ...
... that much harder to eliminate, scientists say , SUNDAY, March ... the AIDS virus in the blood to zero, but HIV ... their pills. Now, research is giving scientists new insight into ... powers of medicine. , In a new study, researchers ...
... ... Medicine residents in hypertension therapy and sleep disorders will receive international recognition at the ... ... the work of two St. Elizabeth Internal Medicine residents in hypertension therapy and sleep ...
... ... certification. Their revolutionary line of quick couplings and plastic fittings are all designed, ... ... -- Kent Systems received their Made in the USA Brand certification. Their revolutionary ...
... The Pediatric Cancer ... Annual “Reaching for the Cure” 10K Run, 5K Run/Walk, and 1K Kids’ Fun Run ... Irvine, CA (PRWEB) March 7, ... “Reaching for the Cure” Half Marathon | 10K 5K Run | 5K Walk | ...
Cached Medicine News:Health News:Improvements needed in genomic test result discussions 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 3Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 4Health News:HIV Hides Out in Bone Marrow Cells 2Health News:St. Elizabeth Medical Residents to Present Research at International Meeting, 2Health News:Kent Systems Received Made in the USA Brand Certification 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3
The GE e-Speed™scanner, the worlds fastest computed tomography (CT) imaging platform, delivers a new advanced tool for physicians to see and diagnose heart disease....
...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...
16mm Slightly Curved sharp Tips; overall length 120mm; Stainless Steel...
Medicine Products: